Search results

Filter (5 in use)

Area of interest

  • Filter by COVID-19 (1)

Type 3 selected

  • Remove filter for NICE advice (1)
  • Remove filter for NICE Pathways
  • Remove filter for News

Last updated 1 selected

  • Remove filter for Last 3 months
  • Filter by Last 6 months
  • Filter by Last year
  • Filter by Last 3 years

Advice programme 1 selected

  • Filter by Medtech innovation briefings (14)
  • Filter by Evidence summaries (4)
  • Filter by Antimicrobial prescribing (3)
  • Remove filter for COVID-19 rapid summaries (1)

1 result

Sorted by Relevance . | Sort by Date

  • NICE advice Remove NICE advice filter
  • NICE Pathways Remove NICE Pathways filter
  • News Remove News filter
  • Last 3 months Remove Last 3 months filter
  • COVID-19 rapid summaries Remove COVID-19 rapid summaries filter
  1. COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)

    ES33 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics

    Type
    Evidence summary: COVID-19 rapid summary
    Published
    15 January 2021